Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Mol Vis ; 18: 1583-93, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22740770

RESUMO

PURPOSE: The aim of this study was to evaluate the expression of the protein annexin A1 (ANXA1), a potent endogenous regulator of the inflammatory process, in ocular toxoplasmosis. METHODS: C57BL/6 female mice were infected using intravitreal injections of either 10(6) tachyzoites of Toxoplasma gondii (RH strain; T. gondii) or PBS only (control groups). After 24, 48, and 72 h, animals were sacrificed and their eyes were harvested for histopathological, immunohistochemical, and ultrastructural immunocytochemical analysis of ANXA1. Human retinal pigment epithelial (RPE) cells (ARPE-19) were infected in vitro with T. gondii and collected after 60, 120, 240 min, and 24 h. RESULTS: Compared with non-infected eyes, an intense inflammatory response was observed in the anterior (24 h after infection) and posterior segments (72 h after infection) of the infected eye, characterized by neutrophil infiltration and by the presence of tachyzoites and their consequent destruction along with disorganization of normal retina architecture and RPE vacuolization. T. gondii infection was associated with a significant increase of ANXA1 expression in the neutrophils at 24, 48, and 72 h, and in the RPE at 48 and 72 h. In vitro studies confirmed an upregulation of ANXA1 levels in RPE cells, after 60 and 120 min of infection with T. gondii. CONCLUSIONS: The positive modulation of endogenous ANXA1 in the inflammatory and RPE cells during T. gondii infection suggests that this protein may serve as a therapeutic target in ocular toxoplasmosis.


Assuntos
Anexina A1/genética , Segmento Anterior do Olho/imunologia , Células Epiteliais/imunologia , Segmento Posterior do Olho/imunologia , Epitélio Pigmentado da Retina/imunologia , Toxoplasmose Animal/imunologia , Toxoplasmose Ocular/veterinária , Animais , Anexina A1/metabolismo , Segmento Anterior do Olho/parasitologia , Segmento Anterior do Olho/patologia , Células Epiteliais/parasitologia , Células Epiteliais/patologia , Feminino , Regulação da Expressão Gênica/imunologia , Humanos , Interferon gama/biossíntese , Interferon gama/imunologia , Injeções Intravítreas , Camundongos , Camundongos Endogâmicos C57BL , Infiltração de Neutrófilos/imunologia , Segmento Posterior do Olho/parasitologia , Segmento Posterior do Olho/patologia , Epitélio Pigmentado da Retina/parasitologia , Epitélio Pigmentado da Retina/patologia , Toxoplasma/imunologia , Toxoplasmose Animal/parasitologia , Toxoplasmose Animal/patologia , Toxoplasmose Ocular/imunologia , Toxoplasmose Ocular/parasitologia , Toxoplasmose Ocular/patologia
2.
J AAPOS ; 11(6): 628-9, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17920320

RESUMO

A 6-year-old girl presented with signs of severe anterior uveitis. After initiating treatment, a cyst like lesion was observed in the anterior chamber that led to the diagnosis of ocular cysticercosis that was ultimately confirmed with histopathologic analysis. Ocular cysticercosis usually affects the extraocular muscle. Infection of the anterior chamber has been described, although to a lesser extent. Because of the usually poor visual prognosis and the controversy in treatment, physicians should be aware of this disease and its different variants of presentation.


Assuntos
Segmento Anterior do Olho/parasitologia , Cisticercose/parasitologia , Cysticercus/isolamento & purificação , Infecções Oculares Parasitárias/parasitologia , Uveíte Anterior/parasitologia , Animais , Compostos Aza/uso terapêutico , Criança , Cisticercose/diagnóstico , Cisticercose/tratamento farmacológico , Quimioterapia Combinada , Infecções Oculares Parasitárias/diagnóstico , Infecções Oculares Parasitárias/tratamento farmacológico , Feminino , Fluoroquinolonas , Humanos , Moxifloxacina , Prednisolona/uso terapêutico , Quinolinas/uso terapêutico , Uveíte Anterior/diagnóstico , Uveíte Anterior/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA